On Wednesday, Shares of Ameriprise Financial, Inc. (NYSE:AMP), lost -1.06% to $128.38.
Ameriprise Financial, plans to declare its second quarter 2015 financial results on Wednesday, July 22, 2015 after the close of the New York Stock Exchange. The company will host a conference call to talk about the results on Thursday, July 23, 2015 at about 9:00 a.m. (ET).
Ameriprise Financial, Inc., through its auxiliaries, provides various financial products and services to individual and institutional clients in the United States and internationally.
Shares of Anacor Pharmaceuticals Inc (NASDAQ:ANAC), inclined 3.29% to $79.09, during its last trading session.
Anacor Pharmaceuticals, declared that Graeme Bell will join Anacor as its new Executive Vice President and Chief Financial Officer. Mr. Bell has more than 20 years of global financial experience in the pharmaceutical industry, and will succeed Geoffrey M. Parker effective as of June 1, 2015. Mr. Parker will remain with Anacor as a consultant to support the transition.
Mr. Bell joins Anacor from Merck & Co., Inc., where he served since 2010 as its Vice President, Country CFO, U.S. Human Health, responsible for the financial oversight and support of Merck’s U.S. pharmaceutical and vaccine business. Preceding to his most recent role, Mr. Bell served in a number of positions of increasing responsibility at Merck, counting as its Global Pharmaceutical Franchises Controller from 2009 to 2010, Country CFO, U.K. from 2008 to 2009 and Global Head of Investor Relations from 2004 to 2008. Mr. Bell has an MBA from Durham University (UK) and is a Fellow of the Chartered Institute of Administration Accountants (CIMA).
Anacor Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform.
At the end of Wednesday’s trade, Shares of Keryx Biopharmaceuticals (NASDAQ:KERX), lost -0.50% to $10.01.
Keryx Biopharmaceuticals, declared that two national insurance providers have added Auryxiato their Medicare Part D formularies. Auryxia is the first and only absorbable, iron-based phosphate binder for the treatment of elevated serum phosphorus levels in people with chronic kidney disease on dialysis. Together, these new formularies will enhance unrestricted access to Auryxia, across Medicare Part D and commercial insurance providers, to about 65 percent of people in the U.S. presently taking phosphate binders.
“The inclusion of Auryxia on these major insurance providers’ Part D formularies, which we expect will start processing claims in the third quarter, significantly expands unrestricted access to Auryxia for people on dialysis and their caregivers,” said Greg Madison, Chief Executive Officer of Keryx Biopharmaceuticals. “We are progressing nicely towards our aim of broad, unrestricted access to about 80 percent of phosphate binder prescriptions, across both Medicare Part D and commercial insurance providers, within 12 months post-approval. Looking ahead, we are focused on ongoing to raise awareness of Auryxia’s clinical profile among the prescribing community and ensuring that the vast majority of dialysis patients have access to this important medicine.”
Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity to bind to phosphate in the gastrointestinal tract and form non-absorbable complexes, in addition to treats iron deficiency anemia.
Finally, McCormick & Company, Incorporated (NYSE:MKC), ended its last trade with 1.45% gain, and close at $81.42.
McCormick & Company, declared that it has signed a contract to acquire 100% of the shares of One World Foods, Inc., seller of Stubb’s barbeque sauces (“Stubb’s”), a privately held company located in Austin, Texas.
- Stubb’s is the leading premium barbeque sauce brand in the U.S. In addition to sauces, Stubb’s products comprise marinades, rubs and skillet sauces. Annual sales of the business are projected to be $30 million in 2015 and are predictable to grow at a double-digit rate annually for the next several years.
- Stubb’s products complement McCormick’s range of grilling items with the addition of authentic, craft barbeque sauces. McCormick plans to drive sales of the Stubb’s brand through expanded distribution, raised household penetration and innovative flavors.
- McCormick has agreed to acquire the business for about $100 million in cash.
- Acquisitions are an important avenue of growth for McCormick. Stubb’s is McCormick’s third acquisition agreement declared in 2015.
McCormick & Company, Incorporated manufactures, markets, and distributes spices, seasoning mixes, condiments, and other flavorful products to the food industry worldwide. It operates through two segments, Consumer and Industrial. The Consumer segment offers spices, herbs, seasonings, and dessert items under the McCormick, Lawry’s, Club House, Zatarain’s, Thai Kitchen, Simply Asia, Ducros, Schwartz, Kamis, Vahiné, DaQiao, Aeroplane, and Kohinoor brand names, in addition to supplies private label items.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
